Promising compound kills range of hard-to-treat cancers by targeting a previously undiscovered vulnerability

A compound called ERX-41 targets a previously unrecognized vulnerability in difficult-to-treat types of cancer including triple-negative breast cancer. The compound will be studied as a drug for clinical translation.

from Latest Science News -- ScienceDaily https://ift.tt/us3NwyM

Comments

Popular posts from this blog

Seismic study reveals key reason why Patagonia is rising as glaciers melt

New method to detect and visualize sperm cells recovered from forensic evidence